Bagheri Maryam, Haghollahi Fedyeh, Shariat Mamak, Jafarabadi Mina, Aryamloo Parastoo, Rezayof Elahe
Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran.
Vali-e-Asr Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran.
J Family Reprod Health. 2020 Sep;14(3):158-165. doi: 10.18502/jfrh.v14i3.4668.
The coronavirus disease 19 (COVID-19) is a highly transmittable and pathogenic viral infection, causes severe acute respiratory syndrome and was spread throughout the world in early 2020. The effects of vitamin and micronutrient supplements on the prevention and treatment of COVID- 19 seems challenging in scientific considerations. On the other side generally, experts warn against over-consumption of these supplements. This study aimed to investigate the vitamin and micronutrient supplementation usage pattern in past history of patients with COVID-19 via a cross-sectional inquiry. Totally 510 patients referring to the infectious disease clinic of Imam Khomeini Hospital in Tehran from March 2020 to May 2020 were recruited. The inclusion criterion was suspected patients for COVID-19 based on clinical findings and CT scans of the lung. The infected patients included both inpatients (171) and outpatients (339). Demographic information, clinical signs, and the supplement pattern use were collected through a questionnaire and the data were statistically analyzed. Vitamin D3 intake was reported in 30% (103 patients) of outpatients and 16.5% (28 patients) of hospitalized patients, which is statistically significant (P=0.001). It shows that, the frequency of vitamin D3 consumption in the outpatient group was higher than inpatient group. This significant difference has also been shown in zinc consumption, in 29 patients (9%) outpatients versus 4 patients (2%) inpatients were reported (P=0.007). Multi nominal regression showed that vitamin D3 intake has a supportive effect and reduces the risk of exacerbation and worsening of the disease. (OR=0.291; 95% CI 0.102-.0834, P=0.022). According to the results of the present study and the findings of other studies, considering the supportive effect of vitamin D3 in reducing the severity of infectious diseases; Clinical trials with an appropriate sample size are recommended to investigate the functional role of this vitamin in improving viral diseases of the respiratory tract.
新型冠状病毒肺炎(COVID-19)是一种具有高度传染性和致病性的病毒感染,可导致严重急性呼吸综合征,并于2020年初在全球传播。从科学角度来看,维生素和微量营养素补充剂对COVID-19的预防和治疗作用似乎具有挑战性。另一方面,一般来说,专家警告不要过度食用这些补充剂。本研究旨在通过横断面调查,研究COVID-19患者既往病史中维生素和微量营养素补充剂的使用模式。2020年3月至2020年5月期间,共有510名前往德黑兰伊玛目霍梅尼医院传染病科就诊的患者被纳入研究。纳入标准为根据临床症状和肺部CT扫描怀疑为COVID-19的患者。感染患者包括住院患者(171例)和门诊患者(339例)。通过问卷调查收集人口统计学信息、临床症状和补充剂使用模式,并对数据进行统计分析。门诊患者中有30%(103例)和住院患者中有16.5%(28例)报告了维生素D3的摄入量,差异具有统计学意义(P=0.001)。这表明,门诊组维生素D3的消费频率高于住院组。锌的消费也显示出这种显著差异,门诊患者中有29例(9%)报告了锌的消费,而住院患者中有4例(2%)报告了锌的消费(P=0.007)。多项回归分析表明,维生素D3的摄入具有支持作用,可降低疾病加重和恶化的风险(OR=0.291;95%CI 0.102-.0834,P=0.022)。根据本研究结果和其他研究结果,考虑到维生素D3在降低传染病严重程度方面的支持作用,建议进行适当样本量的临床试验,以研究该维生素在改善呼吸道病毒性疾病中的功能作用。